Biologic medicines have altered the treatment of diseases like cancer, diabetes and autoimmune diseases. But with high costs, biosimilars are now exponentially increasing and important in improving patient access. So what’s the difference ?
What are biologics?
Biologics are complex medicines which are made from living cells and organisms and used to treat, diagnose and prevent the diseases. They are differ from synthetic drugs due to their complex structures. Ex: Insulin, monoclonal antibodies, vaccines, blood products, gene therapies.
Large and complex molecules
Sensitive to storage and handling
Expensive to develop and manufacture
What are biosimilars?
Biosimilars are highly similar versions of already FDA-approved biologics (reference products). It is not identical but it is closely highly similar to generic, because biologics themselves have natural variability.
Very informative post!! Biosimilars are game changers they match pricey biologics’ results at much lower costs, and most patient switches go smoothly when doctors give clear explanations.
Very informative! Understanding the differences between biosimilars and biologics is essential for healthcare professionals - it helps ensure safe prescribing, supports cost-effective care, and improves patient outcomes
Biosimilars, as the generic counterparts of biologic therapies, offer a compelling option for clinical use—provided they undergo rigorous evaluation and receive regulatory approval. Their adoption can significantly reduce treatment costs while enhancing patient adherence.
Biologics represent innovation at its peak, but biosimilars represent innovation with equity. Both are essential one drives discovery, the other ensures sustainability and access.
Affordable healthcare is always great if it is not compromising on the evidence based trials. And such informations should be widely popularised so that we achieve the goal of Health for all.
